Physician

Wade B May, MD

According to 2025 Medicare claims, Wade May, MD (NPI: 1861682239) practices cardiology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (NPI: 1982689113; TIN: 720993441) and primary practice location at 70503-2632. May is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

May's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,115 traditional Medicare patients, billed 24,125 HCPCS/CPT codes, and received $2,043,732 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 31,751 prescription claims across 2,288 beneficiaries totaling $3,023,812 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 16 claims. Open Payments data shows 49 records totaling $54,143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,076,882 to $2,043,732. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,202,308 to $3,023,812. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $57,999 to $5,767.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,645	40,431	$1,076,882
2016	3,639	35,620	$1,149,501
2017	3,055	26,550	$1,193,053
2018	3,200	22,499	$1,125,382
2019	3,545	20,468	$1,570,779
2020	3,636	25,900	$1,978,539
2021	3,570	27,870	$2,172,734
2022	3,084	23,559	$2,014,779
2023	3,111	21,803	$1,860,231
2024	3,115	24,125	$2,043,732

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,610	24,107	$1,202,308
2016	1,731	25,707	$1,561,422
2017	1,718	24,946	$1,529,136
2018	1,744	21,163	$1,581,521
2019	1,718	17,631	$1,627,164
2020	1,748	19,120	$1,861,562
2021	1,995	22,134	$2,019,393
2022	2,256	29,426	$2,726,482
2023	2,240	31,091	$3,039,870
2024	2,288	31,751	$3,023,812

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	128	$56,400
2016	N/R	32	$2,746
2017	68	279	$7,684
2018	82	259	$6,200
2019	129	281	$6,345
2020	176	399	$14,517
2021	14	91	$2,199
2022	N/R	27	$835
2023	N/R	16	$631
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	769	784	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	885	1,375	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,023	1,158	$62
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,293	2,002	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,630	2,124	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,372	60,036	$1,163,903
Entresto	Sacubitril/Valsartan	504	20,536	$441,081
Xarelto	Rivaroxaban	458	20,667	$377,033
Repatha Sureclick	Evolocumab	293	10,910	$211,054
Jardiance	Empagliflozin	163	6,954	$134,306

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$714	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	9	$53,430	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wade B. May, MD?

Tedicare shows public-source Medicare data for Wade B. May, MD (NPI 1861682239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wade B. May, MD have ACO affiliation data?

Wade B. May, MD is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Wade B. May, MD?

Wade B. May, MD is linked to CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (billing NPI 1982689113) in the available physician profile data.

Does Wade B. May, MD have Open Payments data?

Wade B. May, MD has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.